A ngiotensin I-converting enzyme (ACE, or kininase II) is a single-chain protein with 2 domains (N-and C-domain) named according to their proximity to the N-or C-terminal end. 1,2 The 2-domain, widely distributed enzyme is called somatic ACE, in contrast to the testicular ACE (t-ACE), which represents the C-domain with an additional N-terminal sequence. 3 This originates from an alternate initiation site in intron 12 of the ACE gene. 4 The synthesis of both enzymes is directed, however, by a single gene. Although the homogeneity around the active centers is Ϸ89%, 4 the 2 active sites cleave some substrates at different rates. In addition to active centers and substrate binding sites, the positions of all 7 cysteine residues in each domain are highly conserved (there are no cysteine residues in the other regions of the molecule), which indicates that both domains have some similarity in topological structure. The most important substrates, bradykinin (BK) and angiotensin (Ang) I, are hydrolyzed at both sites, 2, 5 but some of the others are cleaved preferentially by 1 of the sites, which is frequently on the N-domain. Of peptide hormones, for example, the luteinizing hormone-releasing hormone (LHRH) is inactivated mostly by the release of ϽGlu 1 -His 2 -Trp 3 , 6, 7 and the enkephalin precursor Met 5 -Enk-Arg 6 -Phe 7 is converted primarily to enkephalin by the N-domain site. 8, 9 Ang 1-7 10 and the tetrapeptide AcSer-Asp-Lys-Pro (AcSDKP) 11, 12 are also cleaved by the N-domain.
Although the role of individual amino acids in the active center has been well studied, 4 the function of the N-terminal sequence in preserving the integrity of the N-domain of ACE is not known. We have been puzzled by our findings that although human intestinal brush border is quite rich in somatic ACE, 13 ileal fluid contains the highly active intact N-domain of ACE only, but no C-domain is detected there. 14 This separate N-domain has an estimated sequence from 1to 443 amino acids. Thus, we questioned whether the N-terminal end preceding the active center of the N-domain would lend stability to ACE in the protease-rich milieu of the intestine. The integrity of the C-domain attached to plasma membrane can be protected by the N-domain on 1 side and by the transmembrane anchor portion of ACE on the other side. 1, 15 To learn more on the importance of structural elements in ACE, we constructed an ACE molecule that contained the first 141 amino acids of the N-domain without an active center (N-del ACE) and coupled it to the C-domain of human ACE, having the active center and the transmembrane and cytosolic portions of the wild-type ACE (WT-ACE). 4, 8 Because the 2 domains of ACE differ in substrate specificity and presumably in stability, we investigated how these properties are affected by the N-terminal peptide chain, ie, whether, in addition to the individual amino acids in and around the active center, other factors may influence ACE activity. We also wanted to establish whether ACE inhibitors can still potentiate BK effects on its receptor by acting on N-del ACE, having only the C-domain active site.
Methods
Materials BK, Ang, Ang 1-7, AcSDKP, hippuryl-His-Leu (Hip-HisLeu), tissue culture medium, buffers, reagents, and gel filtration columns were obtained from Sigma Chemical Co or from Pharmacia. Fetal bovine serum (FBS) was obtained from Atlanta Biologicals. Benzyloxycarbonyl (Z)-Phe-His-Leu was obtained from Bachem. Enalaprilat and lisinopril were provided by the Merck, Sharp and Dohme Research Division (WesPoint, Pa). Keto-ACE (5 S-5-benzamido-4-oxo-6-phenylhexanoyl-L-proline) was a gift from Dr R.G. Ahlquist at the Stanford Research Institute (Palo Alto, Calif). The wild-type cDNA of ACE was kindly donated by Prof P. Corvol, College de France, Paris, France. Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells were from the American Type Culture Collection. Transfection reagents were from Qiagen. The human active, separate N-domain and C-domain and WT-ACE and rabbit t-ACE were prepared as described. 3, 10, 14 
Culture and Transfection of CHO Cells
Cells were grown and transfected as previously described. 10, 16, 17 CHO cells were plated at density 1ϫ10 5 cells per 60-mm dish 1 day before transfection. 10, 16 Culture and Transfection of HEK293 Cells 
Construction of N-del ACE
There are 2 Bgl II restriction enzyme cleavage sites (A/GATCT) in the ACE cDNA sequence at 533 bp and 2327 bp. This 1.8 kb Bgl II fragment codes for much of the N-domain, including the active site, the bridge peptide 14 that connects N-and C-domain of ACE, and a small portion of C-terminal active domain. The protein sequences around the 2 Bgl II sites are very similar: LDPDLTN versus LEPDLTN. When the Bgl II fragment was removed, there was no shift of the reading frame.
The 1-532 Eco RI-Bgl II and 2328-4020 Bgl II-Eco RI fragments of ACE cDNA were ligated into the dephosphorylated Eco RI site of pcDNA 3 vector (Invitrogen). The ACE-Bgl II deletion-pcDNA3 transfer vector DNA was purified for the transfection of CHO or HEK293 cells.
This deleted form of the ACE molecule (N-del) contains the signal peptide, the N-terminal region, and the C-domain, including the stem peptide, the transmembrane anchor peptide and the cytoplasmic C-terminus. The N-domain contributes 2 cysteine residues, and the C-domain supplies 5 cysteine residues (Figure 1 ).
Transfection With Human B 2 Receptor cDNA
The selected clones were transfected with pcDNA3 vector containing human B 2 BK receptor cDNA by use of the Superfect transfection method. The cells expressing both ACE and B 2 receptors were marked CHO/AB.
Radioligand Binding on Selected Clones
To select the clone with the highest expression of B 2 
Enzyme Solubilization and Assay
Transfected HEK293 or CHO/AB cell monolayers expressing ACE were washed twice with PBS and were then suspended by scraping into 50 mmol/L Tris maleate buffer (pH 7.4) plus 0.5% CHAPS detergent. The cell suspension was incubated at 4°C for 18 hours and was then centrifuged at 100 000g for 1 hour. The supernatant, which contained the detergent solubilized enzyme, was then assayed.
In general, enzymatic activity of ACE was assayed with Hip-HisLeu or Z-Phe-His-Leu. The released His-Leu was measured after adding 100 L of 20 mg/mL o-phthaldialdehyde. 17 
Hydrolysis of Peptides
The rates of hydrolysis of BK and Ang were generally determined at 37°C in 50 mmol/L Tris-maleate buffer (pH 7.4) containing 150 mmol/L NaCl, 100 mol/L substrate, and 10 L of solubilized enzyme from HEK293 cells in the absence or presence of
The hydrolysis of the various peptides by the ACE enzymes was assayed by high-pressure liquid chromatography. It was established that cleavage of the substrates followed zero-order kinetics to the time point of the assay. 9, 20 Effect of Cl -on Activity
The hydrolysis of Z-Phe-His-Leu by solubilized enzymes was measured in NaCl added to assay buffer in concentrations ranging from 0 to 800 mmol/L.
Effect of [SO 4 2؊ ] on Activity
The hydrolysis of Hip-His-Leu was measured in assay buffer containing 150 mmol/L NaCl and either 0 or 900 mmol/L Na 2 SO 4 .
Keto ACE Inhibition
The inhibition of the enzymatic hydrolysis of 1 mmol/L Hip-His-Leu by keto-ACE was determined by preincubating the enzymes for 30 17 In some experiments, [Ca 2ϩ ] i was recorded in a single cell or in 100 cells simultaneously by means of an Attofluor Ratiovision microspectrofluorometer. 5 [
3 H] AA release was determined as described. 5, 17 
Desensitization and Resensitization of the B 2 Receptor
After desensitization of the receptor by initial exposure of cells to BK (0.1 to 1.0 mol/L), the restoration of sensitivity to the agonist (resensitization) was established by measuring either [ 
ACE-Derived Enzymes
To obtain separate active N-and C-domains, purified human kidney ACE 20 was digested with endoprotease AspN (Sigma) for 18 hours at 37°C. 21 The fragments were separated and purified by differential elution from a lisinopril-Sepharose column 14 and by gel filtration on a Superdex 200 FPLC column.
Heat Stability
To compare the heat stability, separate N-domain ACE, C-domain ACE, N-del ACE, and WT-ACE were used. Enzyme samples were diluted 1:10 into 50 mmol/L Tris-maleate (pH 7.4) containing 150 mmol/L NaCl and were incubated for 25 minutes at temperatures ranging from 25°C to 60°C. The enzymatic activity remaining in the aliquots was then measured with Z-Phe-His-Leu.
Protein Assays
Protein concentrations were assayed as before. 16 
Statistics
Probability values were calculated by the unpaired t test by means of Slidewrite software (Advanced Graphics Software).
Results

Hydrolysis of Hip-His-Leu and Z-Phe-His-Leu
The ratio of rates of hydrolysis of Z-Phe-His-Leu to that of Hip-His-Leu 22 was determined for the N-del ACE from HEK293 cells, WT-ACE, N-domain ACE, and t-ACE (Table  1 ). The N-del ACE hydrolyzed Z-Phe-His-Leu Ϸ11 times faster than it did Hip-His-Leu. This ratio was Ϸ3 times larger than with N-domain ACE and 12 times larger than with t-ACE. Clearly, inserting the C-domain into the site of the active portion of the deleted N-domain created an enzyme that hydrolyzes substrates at a different ratio than does WT-ACE, N-ACE, or t-ACE.
Activation of B 2 Receptor
The recombinant ACE with partial N-domain deletion (N-del ACE) has the first 141 amino acids of the N-terminal end of ACE but is missing most of the N-domain sequence (residues 142 to 739). The missing part includes the active center and the so-called "bridge section" 14 16 Another interaction between N-del-ACE and B 2 receptors was also investigated by using ramiprilat to resensitize receptor to BK and measuring [Ca 2ϩ ] i mobilization. Ramiprilat (1 mol/L), the active form of another ACE inhibitor, resensitized the receptor that was desensitized to BK 1.37Ϯ0.21-fold (nϭ5) compared with the first response to BK. When instead of the ACE inhibitor a second dose of BK was given, it was inactive, as noted before. 16, 17 Obviously, this resensitization of the receptor to BK by ACE inhibitor cannot be explained by the inhibition of its enzymatic breakdown.
Consequently, the single active C-domain of N-del ACE anchored to plasma membrane was sufficient to mediate an interaction of ACE with B 2 receptors induced by ACE inhibitor.
Effect of Pertussis Toxin
Treatment of CHO cells expressing both WT-ACE and B 2 with pertussis toxin to block protein abolished the release of AA. Neither 100 nmol/L BK alone (1.05Ϯ0.22-fold over basal rate) nor in combination with ramiprilat (1 mol/L) added to treated CHO cells expressing WT-ACE and B 2 receptor (Figure 2A ) released any significant amount of AA over baseline (nϭ3). Pertussis toxin, however, did not affect the elevation of [Ca 2ϩ ] i by BK, which was stimulated 2.47Ϯ0.6-fold over basal level (nϭ3, PϽ0.05). Furthermore, after the initial B 2 receptor response, the receptor desensitized by BK was resensitized to the BK in the medium by 1 mol/L ramiprilat and increased [Ca 2ϩ ] i 3.4Ϯ0.4-fold over basal level (nϭ3, PϽ0.05) ( Figure 2B ).
Thus the BK-induced AA release and potentiation of this response by ramiprilat are mediated by protein inactivated by pertussis toxin. On the other hand, the BK-induced increase in [Ca 2ϩ ] i as well as the resensitization of this response by ramiprilat are mediated by the toxin-insensitive G␣ q . 19, 23 Inhibition by Keto-ACE Keto-ACE is a relatively specific inhibitor of the C-domain active site of ACE. 10 Therefore, the effectiveness of this inhibitor was determined for the N-del ACE as compared with N-domain and t-ACE. Keto-ACE inhibited the N-del ACE similarly to t-ACE. The IC 50 of keto-ACE for N-del ACE (0.09Ϯ0.002 mol/L) or t-ACE (0.12Ϯ0.03 mol/L) was much lower than the IC 50 for N-domain ACE (15Ϯ7.0 mol/L; PϽ0.005); thus, the inhibition of N-del ACE active center did not differ from that in C-domain.
Activation of ACE Enzymes by Chloride (Cl -)
Chloride ions activate ACE 24, 25 but affect the 2 active sites of ACE unequally. 4, 8 We tested the effect of Cl -on N-del ACE activity between 0 and 800 mmol/L NaCl concentrations (Figure 3 ). Cl -activates N-del ACE differently from either the isolated N-or C-domain or WT-ACE. The N-del ACE has an optimum Cl -of 200 mmol/L, and higher Cl -concentrations inhibit hydrolytic activity. WT-ACE reached a Cl -optimum at 800 mmol/L (Figure 3 ).
Activation by Sulfate [SO 4 2؊ ]
Na 2 SO 4 accelerates the hydrolysis of Hip-Gly-Gly while inhibiting the cleavage of other substrates by ACE. 2 The activity of N-del ACE, t-ACE, and N-domain ACE was measured with and without added 900 mmol/L Na 2 SO 4 with 1.0 mmol/L Hip-His-Leu (Table 2) . Na 2 SO 4 enhanced the hydrolysis of Hip-His-Leu by the N-del ACE 3.3-fold and strongly inhibited (Ϸ80% or more) the cleavage by the other ACE congeners tested, including WT-ACE, N-domain of ACE, and t-ACE.
Hydrolysis of Natural Substrates
We compared the rates of hydrolysis of 4 naturally occurring peptide substrates of ACE (Ang I, Ang1-7, BK, and Ac-SDKP) by both N-del ACE (HEK293 cells) and WT-ACE (Table 3) . N-del ACE cleaved AcSDKP poorly (0.7Ϯ0.5 nmol/min per mg protein) relative to the other peptides (30.8Ϯ4.7 nmol/min per mg for BK and 19.2Ϯ2.3 nmol/min per mg for Ang I). However, N-del ACE cleaved BK faster than Ang I, and WT-ACE acted in the opposite way (Ang I 38.1Ϯ7.0 nmol/min per mg and BK 21.0Ϯ4.9 nmol/min per mg).
Ang 1-7 is cleaved by the N-domain of ACE to Ang 1-5 and a dipeptide, 10 but it inhibits the C-domain of ACE. In this study, the C-domain in N-del ACE was active and cleaved Ang 1-7 (4.1Ϯ0.7 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 protein) Ϸ8 times slower than BK (Table 3) . Therefore, N-del ACE, in contrast to the results obtained with C-domain ACE, 10 acted similarly to N-domain ACE and hydrolyzed Ang 1-7 at a significant rate, but not Ac-SDKP, another substrate of the N-domain.
Heat Stability
The activity of the N-and C-domain of ACE and that of somatic WT-ACE and N-del ACE was measured after they had been incubated 15 minutes at temperatures ranging from 25°C to 60°C (Figure 4) . The stability of the various ACE molecules differed considerably. C-domain ACE was the least stable; it retained 23.3Ϯ2% activity after 15 minutes at 47°C. The N-domain ACE was most stable (55Ϯ6% at 47°C), and WT-ACE, obviously stabilized by N-domain, was similar to N-domain ACE (54Ϯ6% at 47°C). The N-del ACE was more sensitive to denaturation by heat than either the N-domain or WT-ACE (43Ϯ4%) but was less sensitive than C-domain alone (PϾ0.005).
Discussion
We investigated how the N-terminal sequence of ACE, normally distal to cell membrane and facing body conduits, can change some properties of ACE and thus how structural factors can alter the functions of this single-chain, 2-domain enzyme. We constructed an ACE molecule to incorporate the first 141 amino acids of ACE, the mutant (N-del ACE) linked P 141 of the N-domain to D 740 in the C-domain, thus retaining the N-terminal end of ACE but only a single active center in the intact C domain (Figure 1) . N-del ACE differs from WT-ACE, t-ACE, and the other congeners in substrate hydrolysis, in reactivity to anions, and in heat stability. For example, BK was inactivated relatively faster than Ang I by the N-del ACE, but with WT-ACE, the ratio was reversed (Table 3) . Of the other endogenous substrates tested, AcS-DKP was hydrolyzed very slowly by N-del ACE, because this tetrapeptide is a substrate primarily of the N-domain active center. 11, 12 Ang 1-7, a substrate of the N-domain but an inhibitor of the C domain of WT-ACE, 10 was cleaved at an appreciable rate by this modified C-domain.
Z-Phe-His-Leu and Hip-His-Leu are hydrolyzed by both sites of ACE but at different ratios of rates: 1.3 for the WT-ACE and 0.9 for t-ACE. 22 However, the ratio for N-del ACE was entirely different; it cleaved Z-Phe-His-Leu Ϸ11 times faster than the t-ACE representing the unmodified C-domain (Table 1) .
ACE is a chloride-activated enzyme, but activation depends on the structure of the substrate. 7, 8 The hydrolysis of BK is enhanced less by Cl -than that of Ang I, 24, 25 although BK is cleaved more by the C-domain than by the N-domain. In somatic ACE, the N-domain active center is activated at much lower Cl -concentration (10 mmol/L) than that of the C-domain (up to 800 mmol/L). 26 N-del ACE differed, because it was most active in 200 mmol/L NaCl, and higher concentrations of NaCl inhibited N-del ACE. In contrast, the optimal Cl -concentration for WT-ACE was 800 mmol/L. 26 Added Na 2 SO 4 also distinguished N-del-ACE. Sulfate ions enhance the cleavage only of substrates containing C-terminal Gly-Gly 27, 28 ; others are inhibited by this anion. N-del-ACE, however, cleaved Hip-His-Leu 3 times faster in the presence of [SO 4 2Ϫ ], and other ACE congeners were inhibited by Ն80% by Na 2 SO 4 (Table 3) .
When the inactivation of ACE by heating was determined, the isolated N-domain ACE was most stable, and the isolated C-domain was the most labile. N-del ACE was considerably more stable at 47°C than was the isolated C-domain.
The carbohydrate content of N-del ACE would also contribute some of the observed differences because the 1-141 sequence of N-del ACE contains 6 putative sites for N-linked carbohydrate in addition to the sites on the C-domain of ACE. 4 ACE inhibitors (eg, ramiprilat, enalaprilat) potentiate the effects of BK and even of its ACE-resistant analogues on the B 2 receptor indirectly. 6, 16, 17, 29 They are inactive on cells that have B 2 receptor but lack ACE. This cross talk between the enzyme and the receptor is induced also by agents that react only with the N-domain 17 active center. As shown, ACE inhibitors potentiated BK effects on B 2 receptor in the cells that expressed N-del ACE. Consequently, inhibitors that react with either active center of ACE can augment the action of BK and its ACE-resistant analogues on the B 2 receptor. 16, 17 This indirect activation of the B 2 receptor by ACE inhibitors depends on the steric relationship of the enzyme to the receptor. 29 The release of prostaglandins and nitric oxide are among the most important indirect effects of BK 30, 31 ; they are initiated by the complexing of the B 2 receptor with the G␣ i or G␣ q protein. 31 BK. ] i mobilization 17, 33 and its enhancement by ACE inhibitor were not affected (Figure 2 ). The release of [Ca 2ϩ ] i , a consequence of phospholipase C activation, depends on the complexing of the receptor with G␣ q protein. 17, 19 Our findings are consistent with the observations of Williams et al, 22 who created chimeric N-and C-ACE domains in which 13 amino acids within the 60 central amino acid sequence that differ between the domains were exchanged for a corresponding sequence of the other domain. The hydrolysis rates of 2 substrates by the 2 domains indicated that this depended on the sequence surrounding the central regions in each domain rather than on the central regions themselves.
In conclusion, the properties of the C-domain active center were significantly altered by the added N-terminal peptide chain in N-del ACE. Thus, in addition to the amino acids in and around the active center, the structural elements of the N-domain can effectively influence activity at the C-domain.
